If you were to see the phrase ‘Advanced Therapy Medicinal Product’ (ATMP) you might guess, ‘an advanced treatment that is a medicine?’ but you will not get much more from this without doing a lot more homework. What is an ‘Advanced Therapy Medicinal Product’ (ATMP)? Author Dr. Heather Main, Ph.D.. Biomedical …
Read More »Zymomonas mobilis – bacteria that produce green alternative biofuels
One of the biggest reasons for our climate change dilemma is the burning of non-renewable fossil fuels. So, to decrease greenhouse gases in the atmosphere, we need to switch to green biofuels as energy sources. One sustainable alternative to petroleum fuel is bioethanol, which is also a lot healthier for …
Read More »Weekly reads & stem cell news: New York axes NYSTEM, fetal tissue rules reversed, pubs & more
It’s been a week with a wide variety of regenerative medicine papers and stem cell news. Here’s my earlier take from a few days ago on the Belmonte-led human-monkey chimeric embryo paper in Cell that broke this week. A few days ago I also put up a new video on …
Read More »Settling an Armed Conflict with a Sworn Enemy – CSS Blog Network
Image courtesy of Flickr. President Santos signing the peace agreement with the FARC on 26 September 2016. Less than a week later, the deal was rejected in a plebiscite. Mediation Perspectives is a regular series of blog contributions by the CSS Mediation Support Team and occasional guest authors. Intrastate conflicts are notoriously …
Read More »The EU draft Regulation on AI: a threat to labour protection?
In early April 2021, a draft EU Regulation on a European Approach to Artificial Intelligence was leaked to the press. The draft has been already attentively commented, among others, by Dr Michael Veale (UCL Faculty of Laws). The draft Regulation, however, raises many specific concerns about the use of AI …
Read More »New EU Rules on Supply Chain Due Diligence: A Net Cast Too Wide?
The EU is slowly but surely setting the stage for new legislation on supply chain due diligence that will be expansive in its reach and global in its impact. As it makes human rights’ due diligence a business imperative, the EU will send a signal that it is willing to …
Read More »Monkey human embryo chimera Cell paper: exciting, ethically complex direction
A new Cell paper from an international team led by Juan Carlos Izpisua Belmonte pushes human embryo chimera embryo research further than ever before. It is both exciting work and raises many complex bioethics questions at the same time. Example of a human embryo chimera made by putting human stem …
Read More »Dust may be an efficient matrix for environmental monitoring of SARS-CoV-2
A new viral disease surveillance tool: Indoor dust as a matrix for surveillance of COVID-19, published in mSystems. Throughout the COVID-19 pandemic, large scale monitoring of SARS-CoV-2 has helped to prevent spread and inform public health decisions. This has largely been done through individual sampling (ie nasal and saliva sample …
Read More »A Cas9-based Genome Editing System Universal to All E. Coli Strains
This post was contributed by guest bloggers, Qi Li, a lecturer at Sichuan Normal University, Jieze Zhang, an intern in the Yang Lab, and Sheng Yang, a professor in synthetic biology from the Chinese Academy of Sciences.
Read More »Sunset for the office?
Will offices close in favour of telework/remote work? It is unclear whether telework/remote work will be taken up (where feasible) in a significant manner once businesses more widely re-open. The question of continued use of office space (as well as in what capacity and size) has been posed and widely …
Read More »